Faculty Information - YOSHINAGA Kentarou

（Last updated : 2026-05-12 13:45:30）

YOSHINAGA Kentarou
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Hematology

Position Associate Professor

■ Published papers

1.	Original article	JAK2 V617F mutation is rare in idiopathic erythrocytosis: a difference from polycythemia vera. 2008
2.	Case report	Anti-lymphoma effect of naproxen and indomethacin in a patient with relapsed diffuse large B-cell lymphoma. 2001
3.	Original article	Crystalglobulin-Induced Nephropathy and Cardiac Nonamyloidotic Immunoglobulin Deposition Disease: A Fatal Case Report. 2026/04/24
4.	Review article	Rh null erythrocytosis 2023/09/30
5.	Review article	Hereditary pyropoikilocytosis 2023/09
6.	Original article	Very Early Increased Platelet Count within a Week after Initiation of High-Dose Dexamethasone Treatment Is Associated with Long-Term Response in Newly Diagnosed Immune Thrombocytopenia Patients. 2022/02
7.	Original article	Genetic alterations in patients with chronic leukocytosis and persistent thrombocytosis 2022/01/18
8.	Original article	Genetic alterations in patients with chronic leucocytosis and persistent thrombocytosis. 2022
9.	Original article	High PRAME expression is associated with poor survival and early disease progression in myelodysplastic syndromes with a low bone marrow blast percentage. 2021/10
10.	Case report	Successful Rituximab Treatment in Thrombotic Thrombocytopenic Purpura Patients Complicated by Other Autoimmune Disorders: Two Case Reports. 2021/09
11.	Original article	Correction to: Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities. 2020/11
12.	Original article	Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities. 2020/11
13.	Original article	Phase I study of cellular therapy using ex vivo expanded NK cell from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients. 2020/04
14.	Original article	Reduced PLCG1 expression is associated with inferior survival for myelodysplastic syndromes. 2019/11
15.	Original article	Expression analysis of genes located within the common deleted region of del(20q) in patients with myelodysplastic syndromes. 2019/09
16.	Original article	Herpes zoster after autologous haematopoietic stem cell transplantation without antiviral prophylaxis. 2019/09
17.	Case report	A Case of Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma With Lung Lesion. 2019/01
18.	Original article	Tumor suppressor gene methylation on the short arm of chromosome 1 in chronic myelogenous leukemia. 2017/05
19.	Original article	Translocation (9;12)(q34.1;p13.?3) Resulted in ETV6-ABL1 Fusion in a Patient with Philadelphia Chromosome-Negative Chronic Myelogenous Leukemia. 2016/11
20.	Case report	Successful Treatment of Ascites using a Denver Peritoneovenous Shunt in a Patient with Paroxysmal Nocturnal Hemoglobinuria and Budd-Chiari syndrome 2016/10
21.	Original article	Impact of Elevated Hemoglobin and Serum Protein on Vasovagal Reaction from Blood Donation. 2016/02
22.	Original article	Identification of the SOX5 gene as a novel IGH-involved translocation partner in BCL2-negative follicular lymphoma with t(12;14)(p12.2;q32). 2015/11
23.	Original article	Peroxiredoxin 2 expression is increased in neutrophils of patients with refractory cytopenia with multilineage dysplasia. 2014/09
24.	Original article	Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source. 2014/01
25.	Original article	L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma. 2013/11
26.	Original article	Usefulness of the revised international prognostic index for diffuse large B-cell lymphoma patients treated with rituximab-based chemotherapy 2013/03
27.	Original article	Usefulness of (18)F-FDG PET/CT for detecting lesions in patients with POEMS syndrome 2012/12
28.	Case report	Acquired Hemopholia A in a Patient with Essential Thrombocytopenia 2012
29.	Case report	Angioimmunoblastic T-cell lymphoma with marked polyclonal plasmacytosis in peripheral blood and bone marrow mimicking plasma cell leukemia 2011/07
30.	Original article	Abberant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia 2011
31.	Case report	Disseminated Cryptococcosis in a Non-Hodgkin's Lymphoma Patient with Late-Onset Netropenia Following Rituximab-CHOP Chemotherapy: A Case Report and Literature Review. 2011
32.	Original article	Infrequent V617F mutation of the JAK2 gene in myeloid leukemia and its absence in lymphoid malignancies in Japan. 2008
33.	Case report	A case showing transition from T-cell-rich polymorphic lesion to diffuse large B-cell lymphoma. 2007
34.	Original article	Lack of nucleophosmin mutation in patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities. 2007
35.	Original article	K-252a induced polyploidization and differentiation of a human megakaryocytic cell line, Meg-J 1998
36.	Original article	Effect of thrombopoietin (c-mpl ligand) alone and in combination with other hematopoietic growth factors on human megakaryopoiesis in serum-free cultures 1997
37.	Original article	Mechanism of action of antithymocyte globulin in the treatment of aplastic anemia: in vitro evidence for the presence of immunosuppressive mechanism 1997
38.	Original article	Effect of interkeukin 11 on normal and pathological thrombopoiesis. 1996
39.	Original article	Cytotoxic drug-induced pneumonia and possible augmentation by G-CSF - clinical attention. 1993
Display 5 items
Display all(39)

■ Academic conference presentation

1.	Conditional survival after autologous hematopoietic cell transplantation for high-risk lymphomas （口頭，一般） 2025/10/12
2.	THE EFFECT OF KIR HAPLOTYPE ON CLINICAL COURSE IN PATIENTS WITH METHOTREXATE-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS （ポスター掲示，一般） 2025/06/14
3.	Clinical course of immune thrombocytopenia after COVID-19 vaccination （口頭，一般） 2022/10/16
4.	Clinical features of MTX-associated lymphoproliferative disorders in rheumatoid arthritis patients （口頭，一般） 2022/10/16
5.	4 cases of COVID-19 infection in patients with hematological diseases （ポスター掲示，一般） 2021/09/23
6.	A case of primary mediastinal large B-cell lymphoma with pancreas involvement （ポスター掲示，一般） 2021/09/23
7.	Retrospective analysis of chronic myelomonocytic leukemia （ポスター掲示，一般） 2021/09/23
8.	Safety and efficacy of obinutuzumab-based chemoimmunotherapy for follicular lymphoma patients （ポスター掲示，一般） 2021/09/23
9.	Successful treatment with daratumumab in multiple myeloma patient with severe renal impairment （ポスター掲示，一般） 2021/09/23
10.	Prognostic Significance of Reduced BCAS4 expression in Bone Marrow Cells of Patients with Myelodysplastic Syndromes （ポスター掲示，一般） 2019/12/09
11.	Clinical Features of Post-Transplant Lymphoproliferative Disease Are Different between Kidney-Transplant Recipients from a Cadaveric Donor and Those from a Living Donor （ポスター掲示，一般） 2019/12/08
12.	Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/ II Clinical Trial in Progress （ポスター掲示，一般） 2019/12/08
13.	Successful combined Treatment of blinatumomab and donor lymphocyte infusion after haploidentical hematopoietic cell transplantation in a relapsed Ph+ALL patient with BCR/ABL1 compound mutation （ポスター掲示，一般） 2019/08/30
14.	Non-Hodgkin lymphoma in patients with myeloproliferative neoplasms （ポスター掲示，一般） 2019/06/15
15.	Overexpression of protein tyrosine phosphatase non-receptor type1 causes STAT5 dephosphorylation, resulting in suppression of cell growth signal in K562 human leukemia cells （ポスター掲示，一般） 2019/06/15
16.	Promoter methylation of tumor suppressor genes on the short arm of chromosome 1 in myelodysplastic syndrome and acute myeloid leukemia. （ポスター掲示，一般） 2019/06/14
17.	Allogeneic bone marrow transplantation from unrelated donor for a patient with idiopathic CD4+ lymphocytopenia （ポスター掲示，一般） 2018/11/02
18.	Eculizumab is effective for Budd-Chiari syndrome with paroxysmal nocturnal hemoglobinuria （ポスター掲示，一般） 2018/10/13
19.	Possible somatic mosaicism of the the JAK2 gene in patients with myeloproliferative neoplasms （ポスター掲示，一般） 2018/06/16
20.	Clinical significance of reduced expression of the genes located within common deleted region of del(20q) in patients with myelodysplastic syndromes （ポスター掲示，一般） 2018/06/15
21.	Clinical Implication of serum ferritin lebel at diagnosis in patients with myelodysplastic syndromes （抄録のみ） 2018/06/14
22.	Herpes zoster after autologous hematopoietic stem cell transplantation without antiviral prophylaxis （ポスター掲示，一般） 2018/03/20
23.	Early increased platelet count is a predictive factor for a long-term response in high-dose dexamethasone treatment for newly-diagnosed immune thrombocytopenia patients （ポスター掲示，一般） 2017/12/09
24.	Long term efficacy of high dose dexamethasone for immune thrombocytopenia （口頭，一般） 2017/10/22
25.	Mutations and sytogenetic abnormalities are predictive of predictive of progression in idiopathic leukosytosis （口頭，一般） 2017/10/22
26.	Anti-CD20/anti-KIR antibody treatment enhances the cytotoxicity of NK cells against lymphoma cells （ポスター掲示，一般） 2017/10/21
27.	Clinical characteristics of CNS relapse in patients with diffuse large B-cell lymphoma （ポスター掲示，一般） 2017/10/20
28.	HSV and VZV disease during the first year after autologous hematopoietic stem cell transplantation （口頭，一般） 2017/10/20
29.	Retrospective analyse of methotrexate associated lymphoma （口頭，一般） 2017/10/20
30.	Acquired pure red cell aplasia associated with lymphoproliferative diseases in erythropoietin-refractory anemia patients on dialysis （抄録のみ，一般） 2017/06/23
31.	Molecular mechanisms and clinical significance of reduced PTPN1 expression in myelodysplastic syndromes （ポスター掲示，一般） 2017/06/23
32.	Mutations of the JAK2 gene and cytogenetic abnormalities are predictive of progression to hematological neoplasms in patients with idiopathic leukocytosis （抄録のみ，一般） 2017/06/23
33.	Autologous peripheral blood stem cell harvesting/ transplantation using modified Dexa-BEAM/BEAM regimens for the patients with high-risk lymphomas: a single center retrospective study. （ポスター掲示，一般） 2016/10/29
34.	Clinical significance of reduced PLCG1 expression in myelodysplastic syndromes （口頭，一般） 2016/10/13
35.	Seven cases of non-Hodgkin B-cell lymphoma with heart involvement at diagnosis （口頭，一般） 2016/10/13
36.	Fractionated ICE with rituximab is safe and effective for relapse/refractory DLBCL patients with severe comorbidities （ポスター掲示，一般） 2015/12/06
37.	Reduced PLCG1 expression is associated with inferior survival in myelodysplastic syndromes （ポスター掲示，一般） 2015/12/05
38.	Progression to myeloproliferative neoplasms was associated with mutations of the JAK2 and CALR genes in patients with idiopathic leukocytosis and thrombocytosis （ポスター掲示，一般） 2015/06/12
39.	High PRAME expression is associated with shorter survival in myelodysplastic syndromes （口頭，一般） 2014/11/01
40.	Methylation of tumor suppressor genes in chronic myelogenous leukemia （口頭，一般） 2014/11/01
41.	RELAL-88 exhibited high remission rates in refractory or relapsed adult precursor lymphoid neoplasms （口頭，一般） 2014/10/31
42.	Promoter methylation of the tumor suppressor genes on the short arm of chromosome 1 in chronic myelogenous （ポスター掲示，一般） 2014/06/13
43.	Expansion of NK cells from peripheral blood mononuclear cells using GMP-compliant substances without feeder cells for adaptive NK cell therapy （抄録のみ，一般） 2014/06/12
44.	Mutations of the calreticulin gene in myeloproliferative neoplasms in japanese patients （抄録のみ，一般） 2014/06/12
45.	Prognostic Implications Of PRAME Expression Levels In Myelodysplastic Syndromes. （ポスター掲示，一般） 2013/12/08
46.	Analysis of L265P mutation in the MYD88 gene in Waldenstrom's macroglobulinemia （口頭，一般） 2013/10/12
47.	Long term efficacy of laparoscopic splenectomy for immune thrombocytopenia （ポスター掲示，一般） 2013/10/12
48.	Thrombotic thrombocytopenic purpura diagnosed after a twenty-year history of thrombocytopenia （ポスター掲示，一般） 2013/10/12
49.	A case of acute myeloid leukemia with t(11;19) (q23;p13.1) accompanied by severe DIC （口頭，一般） 2013/10/11
50.	Analysis of expression of genes in common deleted region of del(20q) in MDS cases （ポスター掲示，一般） 2013/10/11
51.	Coexistance of lupus anticoagulant, factor VIII and IX inhibitor in a patient with scleroderma （ポスター掲示，一般） 2013/10/11
52.	Doner cell leukemia after cord blood transplantation: Compareing to BM as transplanted source （ポスター掲示，一般） 2013/10/11
53.	Peroxiredoxin 2 expression is elevated in the neutrophils of patients with myelodysplastic syndromes （ポスター掲示，一般） 2013/10/11
54.	Frequent mutation of the MYD88 gene in macroglobulinemia （ポスター掲示，一般） 2013/06/15
55.	Clinical course of adult non-severe aplastic anemia （ポスター掲示，一般） 2011/10/14
56.	Long-term clinical outcome of patients with chronic myeloid leukemia treated with interferon-alpha （ポスター掲示，一般） 2011/10/14
57.	Methylation and mutation analysis on the RIZ1 gene in chronic myelocytic leukemia （ポスター掲示，一般） 2011/10/14
58.	Factors which effect the responsiveness of thalidomide treatment for patients with multiple myeloma （ポスター掲示，一般） 2009/10/24
59.	Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone （ポスター掲示，一般） 2009/10/24
60.	R-CHOP therapy for primary thyroid diffuse large B-cell lymphoma （ポスター掲示，一般） 2009/10/24
61.	Clinicopathological characteristics of five cases of primary effusion lymphoma （ポスター掲示，一般） 2009/10/23
Display 5 items
Display all(61)